In COVID-19-associated coagulopathy, patients often present initially with increased fibrinogen levels, elevated D-dimers, but with only minor changes in PT and platelet count compared to acute bacterial sepsis, which can lead to thrombocytopenia, prolonged prothrombin times, and decreased antithrombin levels [8, 9, 15–18]. Here, F2 is linked to COVID-19.